Emmanuelle J Meuillet

Emmanuelle J. Meuillet is an accomplished scientist, inventor, and entrepreneur focusing on drug discovery and development. Dr. Meuillet obtained a PhD in Biochemistry and Pharmacology from the Louis Pasteur University (France). She completed post-doctoral training at the Children’s Memorial Hospital at Northwestern University in Chicago and at the University of Arizona Comprehensive Cancer Center in Tucson. Over the years, Dr. Meuillet has managed many NIH funded programs bringing in over $9M for research in oncology and experimental therapeutics. She is an experienced manager of national and international multidisciplinary innovative projects. She founded two biotech companies, Phusis Therapeutics, Inc. in 2009 and Theraxen Technologies, LLC in 2016 advancing the development of small molecules. Dr. Meuillet is a consultant for the NIH, DoD, and various foundations and organizations in the US and Europe. She is the author of more than fifty peer-reviewed manuscripts and reviews, she is an inventor on three patents and she belongs to several editorial boards for specialized cancer journals.